BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31694720)

  • 1. Cost-effectiveness analysis (CEA) of IMRT plus C12 boost vs IMRT only in adenoid cystic carcinoma (ACC) of the head and neck.
    Jensen AD; Debus J
    Radiat Oncol; 2019 Nov; 14(1):194. PubMed ID: 31694720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined intensity-modulated radiotherapy plus raster-scanned carbon ion boost for advanced adenoid cystic carcinoma of the head and neck results in superior locoregional control and overall survival.
    Jensen AD; Nikoghosyan AV; Poulakis M; Höss A; Haberer T; Jäkel O; Münter MW; Schulz-Ertner D; Huber PE; Debus J
    Cancer; 2015 Sep; 121(17):3001-9. PubMed ID: 26043145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-irradiation of adenoid cystic carcinoma: analysis and evaluation of outcome in 52 consecutive patients treated with raster-scanned carbon ion therapy.
    Jensen AD; Poulakis M; Nikoghosyan AV; Chaudhri N; Uhl M; Münter MW; Herfarth KK; Debus J
    Radiother Oncol; 2015 Feb; 114(2):182-8. PubMed ID: 25640299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COSMIC: A Regimen of Intensity Modulated Radiation Therapy Plus Dose-Escalated, Raster-Scanned Carbon Ion Boost for Malignant Salivary Gland Tumors: Results of the Prospective Phase 2 Trial.
    Jensen AD; Nikoghosyan AV; Lossner K; Haberer T; Jäkel O; Münter MW; Debus J
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):37-46. PubMed ID: 26279022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inverse planned stereotactic intensity modulated radiotherapy (IMRT) in the treatment of incompletely and completely resected adenoid cystic carcinomas of the head and neck: initial clinical results and toxicity of treatment.
    Münter MW; Schulz-Ertner D; Hof H; Nikoghosyan A; Jensen A; Nill S; Huber P; Debus J
    Radiat Oncol; 2006 Jun; 1():17. PubMed ID: 16756669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-LET radiotherapy for adenoid cystic carcinoma of the head and neck: 15 years' experience with raster-scanned carbon ion therapy.
    Jensen AD; Poulakis M; Nikoghosyan AV; Welzel T; Uhl M; Federspil PA; Freier K; Krauss J; Höss A; Haberer T; Jäkel O; Münter MW; Schulz-Ertner D; Huber PE; Debus J
    Radiother Oncol; 2016 Feb; 118(2):272-80. PubMed ID: 26164774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined treatment of adenoid cystic carcinoma with cetuximab and IMRT plus C12 heavy ion boost: ACCEPT [ACC, Erbitux® and particle therapy].
    Jensen AD; Nikoghosyan A; Hinke A; Debus J; Münter MW
    BMC Cancer; 2011 Feb; 11():70. PubMed ID: 21320355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs of care in a matched pair comparison of intensity-modulated radiation therapy (IMRT) versus conventional radiation therapy (CRT) for the treatment of head and neck cancer.
    Sheets NC; Wheeler SB; Kohler RE; Fried DV; Brown PM; Chera BS
    Am J Clin Oncol; 2014 Dec; 37(6):539-44. PubMed ID: 23466583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenoid cystic Carcinoma and Carbon ion Only irradiation (ACCO): Study protocol for a prospective, open, randomized, two-armed, phase II study.
    Lang K; Adeberg S; Harrabi S; Held T; Kieser M; Debus J; Herfarth K
    BMC Cancer; 2021 Jul; 21(1):812. PubMed ID: 34266402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bimodality treatment of patients with pelvic adenoid cystic carcinoma with photon intensity-modulated radiotherapy plus carbon ion boost: a case series.
    Bernhardt D; Sterzing F; Adeberg S; Herfarth K; Katayama S; Foerster R; Hoerner-Rieber J; König L; Debus J; Rieken S
    Cancer Manag Res; 2018; 10():583-588. PubMed ID: 29618938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensity-modulated radiation therapy (IMRT) versus 3-dimensional conformal radiation therapy (3D-CRT) for head and neck cancer: cost-effectiveness analysis.
    Marta GN; Weltman E; Ferrigno R
    Rev Assoc Med Bras (1992); 2018 Apr; 64(4):318-323. PubMed ID: 30133610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbon ion therapy (C12) for high-grade malignant salivary gland tumors (MSGTs) of the head and neck: do non-ACCs profit from dose escalation?
    Jensen AD; Poulakis M; Vanoni V; Uhl M; Chaudhri N; Federspil PA; Freier K; Krauss J; Debus J
    Radiat Oncol; 2016 Jul; 11(1):90. PubMed ID: 27386864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-Effectiveness Analysis of Intensity Modulated Radiation Therapy Versus 3-Dimensional Conformal Radiation Therapy for Preoperative Treatment of Extremity Soft Tissue Sarcomas.
    Richard P; Phillips M; Smith W; Davidson D; Kim E; Kane G
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(3):999-1008. PubMed ID: 27130792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of a combination treatment with intensity modulated radiotherapy and active raster-scanning carbon ion boost for adenoid cystic carcinoma of the minor salivary glands of the nasopharynx.
    Akbaba S; Ahmed D; Lang K; Held T; Mattke M; Hoerner-Rieber J; Herfarth K; Rieken S; Plinkert P; Debus J; Adeberg S
    Oral Oncol; 2019 Apr; 91():39-46. PubMed ID: 30926061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of radiation therapy for locally advanced adenoid cystic carcinomas with infiltration of the skull base using photon intensity-modulated radiation therapy (IMRT) and a carbon ion boost.
    Schulz-Ertner D; Didinger B; Nikoghosyan A; Jäkel O; Zuna I; Wannenmacher M; Debus J
    Strahlenther Onkol; 2003 May; 179(5):345-51. PubMed ID: 12740662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of prostate boost with high-dose-rate brachytherapy versus intensity-modulated radiation therapy in the treatment of intermediate-high risk prostate cancer.
    Vu CC; Blas KG; Lanni TB; Gustafson GS; Krauss DJ
    Brachytherapy; 2018; 17(6):852-857. PubMed ID: 30076108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Phase 1/2 ACCEPT Trial: Concurrent Cetuximab and Intensity Modulated Radiation Therapy with Carbon Ion Boost for Adenoid Cystic Carcinoma of the Head and Neck.
    Adeberg S; Akbaba S; Lang K; Held T; Verma V; Nikoghosyan A; Bernhardt D; Münter M; Freier K; Plinkert P; Hauswald H; Herfarth K; Rieken S; Debus J; Jensen AD
    Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):167-173. PubMed ID: 31586664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicity and cost-effectiveness analysis of intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy for postoperative treatment of gynecologic cancers.
    Chen LA; Kim J; Boucher K; Terakedis B; Williams B; Nickman NA; Gaffney DK
    Gynecol Oncol; 2015 Mar; 136(3):521-8. PubMed ID: 25562668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protons in head-and-neck cancer: bridging the gap of evidence.
    Ramaekers BL; Grutters JP; Pijls-Johannesma M; Lambin P; Joore MA; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1282-8. PubMed ID: 23273998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of intensity-modulated radiotherapy in oropharyngeal cancer.
    Yong JH; Beca J; O'Sullivan B; Huang SH; McGowan T; Warde P; Hoch JS
    Clin Oncol (R Coll Radiol); 2012 Sep; 24(7):532-8. PubMed ID: 22739256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.